Purchases and Sales Made in Q3 2024 in Bio Line Rx Ltd. (BLRX)
This table provides information about the institutional ownership of Bio Line Rx Ltd. (BLRX) during Q3 2024. The information is specifically focused on institutions that hold shares of BioLineRx Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
129K+ 188.64% |
$68.4K - $112K
|
198K
$94.8K
|
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
44.1KNew |
$23.4K - $38.4K
|
44.1K
$21.2K
|
|
|
Nov 01, 2024
Q3 2024
|
Atria Investments LLC
Charlotte, NC |
BUY
|
- |
29.2K+ 27.86% |
$15.5K - $25.4K
|
134K
$64.3K
|
|
|
Nov 06, 2024
Q3 2024
|
Envestnet Asset Management Inc
|
BUY
|
- |
25.4K+ 11.86% |
$13.4K - $22.1K
|
239K
$115K
|
|
|
Nov 14, 2024
Q3 2024
|
Captrust Financial Advisors
Raleigh, NC |
BUY
|
- |
16.2KNew |
$8.57K - $14.1K
|
16.2K
$7.76K
|
|
|
Oct 29, 2024
Q3 2024
|
Baader Bank Aktiengesellschaft
Unterschleissheim, 2M |
BUY
|
- |
13.3KNew |
$7.02K - $11.5K
|
13.3K
$6.36K
|
|
|
Nov 14, 2024
Q3 2024
|
Weaver Consulting Group
|
BUY
|
- |
12.8K+ 75.8% |
$6.8K - $11.2K
|
29.7K
$14.3K
|
|
|
Oct 23, 2024
Q3 2024
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
10.5KNew |
$5.57K - $9.14K
|
10.5K
$5.04K
|
|
|
Nov 08, 2024
Q3 2024
|
Lpl Financial LLC
Fort Mill, SC |
BUY
|
- |
10K+ 12.2% |
$5.3K - $8.7K
|
92K
$44.2K
|
|
|
Nov 13, 2024
Q3 2024
|
Cetera Investment Advisers
Schaumburg, IL |
BUY
|
- |
8.49K+ 11.85% |
$4.5K - $7.39K
|
80.2K
$38.5K
|
|
|
Nov 12, 2024
Q3 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
6.87K+ 26.69% |
$3.64K - $5.98K
|
32.6K
$15.7K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 11, 2024
Q3 2024
|
Creative Planning
Overland Park, KS |
SELL
|
- |
-99- 0.76% |
$52.5 - $86.1
|
13K
$6.23K
|
|
|
Nov 13, 2024
Q3 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-200- 14.22% |
$106 - $174
|
1.21K
$579
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-496- 33.51% |
$263 - $432
|
984
$472
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.5K- 99.93% |
$795 - $1.31K
|
1
$0.48
|
|
|
Nov 08, 2024
Q3 2024
|
Atria Wealth Solutions, Inc.
New York, NY |
SELL
|
- |
-5.2K- 5.23% |
$2.76K - $4.52K
|
94.1K
$45.2K
|
|
|
Oct 23, 2024
Q3 2024
|
Values First Advisors, Inc.
|
SELL
|
- |
-6.24K- 3.06% |
$3.31K - $5.43K
|
198K
$94.8K
|
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-21K- 37.48% |
$11.1K - $18.3K
|
35K
$16.8K
|
|
|
Nov 14, 2024
Q3 2024
|
Geneos Wealth Management Inc.
|
SELL
|
- |
-34K- 88.31% |
$18K - $29.6K
|
4.5K
$2.16K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-100K- 84.74% |
$53.1K - $87.1K
|
18K
$8.66K
|
|
|
Nov 14, 2024
Q3 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-1.09M- 55.64% |
$576K - $946K
|
866K
$416K
|